about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More
1.90
-0.10
(-5.00%)
21,311
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
VivoSim Labs Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..